U.S. Banks Stock News

In its recently reported second quarter of fiscal 2026, Conagra Brands posted sales of US$2,979.1 million versus US$3,195.1 million a year earlier, swung from net income of US$284.5 million to a net loss of US$663.6 million, and recorded very large non-cash goodwill and brand impairment charges alongside continued dividend payments and modest organic sales guidance of 1% decline to 1% growth. These results come as Conagra contends with softening demand, shrinking unit sales and evolving...

If you are wondering whether Taiwan Semiconductor Manufacturing is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price still makes sense. The stock has climbed 7.9% over the last week, 5.0% over the past month, and is now up 48.2% year to date and 324.2% over three years. The big question is whether you are late to the party or the growth story still has room to run. Much of this momentum has been driven by surging...

United Natural Foods (UNFI) just filed a roughly $50 million shelf registration tied to an employee stock ownership plan, a low drama move that still matters for how investors think about dilution and flexibility. See our latest analysis for United Natural Foods. That ESOP related shelf comes as investors reassess United Natural Foods after a strong run, with the share price at $33.8 and a roughly 22.5% year to date share price return but a softer 3 year total shareholder return. This...

In December 2025, Hormel Foods appointed veteran marketer Jason Levine as its first enterprise-wide chief marketing officer and completed a new partnership structure for the Justin’s brand, while SKIPPY and Milk Bar jointly revealed a co-branded Chocolate Peanut Butter Crunch Pie now available online and in Milk Bar bakeries. Together, these moves signal Hormel’s push to sharpen its consumer focus, leverage data-driven brand building, and unlock more value from its snacking and nut-butter...

ImmunityBio (IBRX) just added another data point to ANKTIVA’s story, with new Journal of Urology results showing the ANKTIVA plus BCG combo holding up at 12 and 36 months in difficult bladder cancer. See our latest analysis for ImmunityBio. Against that backdrop, ImmunityBio’s latest ANKTIVA milestones and fresh EMA traction come as the 90 day share price return of minus 13.01 percent and one year total shareholder return of minus 18.63 percent show that momentum is still rebuilding from a...

On December 16, 2025, Northwest Natural Holding Company announced two long-dated, fixed-rate callable mortgage bond offerings totaling US$200 million in principal, alongside planned 2026 leadership changes in its legal and compliance functions. The combination of fresh long-term funding and a transition to a new General Counsel and Chief Compliance Officer highlights how Northwest Natural is reshaping both its balance sheet and governance framework ahead of MardiLyn Saathoff’s April 2026...

In recent months, UnitedHealth Group has responded to independent audits by outlining 23 operational reforms across its Medicare Advantage and Optum Rx pharmacy benefit operations, while also managing ongoing Department of Justice investigations into its billing practices. This combination of audit-driven changes and heightened regulatory attention is pushing the company to overhaul governance, automation, and transparency in ways that could materially reshape how it delivers and pays for...

If you are wondering whether Expeditors International of Washington is still worth considering after its big run, or if the easy money has already been made, this breakdown is designed to help you decide with less guesswork. The stock has climbed 1.2% over the last week, 5.1% over the past month, and is now up 37.8% year to date and 38.0% over the last year, building on gains of 50.8% over 3 years and 69.7% over 5 years. Recent attention around global trade routes, freight demand stability,...

On 12 December 2025, UBS analyst Danielle Antalffy initiated coverage of PROCEPT BioRobotics with a bullish view, highlighting expectations for expanding revenue, improving gross margins, and cost efficiencies that could support profitability by 2027. This upbeat initiation adds to already optimistic analyst sentiment around PROCEPT’s urology-focused surgical robotics platform, with no Sell ratings and most covering analysts expecting meaningful growth in its Aquablation-based...

If you are wondering whether Tesla is still a buy at today’s price, you are not alone. This article is going to walk through what the numbers say about its current valuation. Over the last month the stock has climbed 16.2%, adding to a 28.0% gain year to date and a 330.7% return over three years. This naturally raises questions about how much upside is really left. Recent headlines have focused on Tesla’s push to deepen its AI and autonomous driving capabilities, regulatory approvals for...

Whether you see Pony AI as a hidden bargain or already priced for perfection, this piece will walk through what the current share price really implies. The stock has been lively lately, climbing 10.7% over the last week, 24.5% over the past month, and 20.4% over the last year, even though it is only up 3.2% year to date from its last close at $15.68. Investors have been reacting to a steady drumbeat of headlines around autonomous driving partnerships and regulatory milestones in key U.S. and...

Hubbell (HUBB) has been quietly rewarding patient shareholders, with the stock up about 9% over the past 3 months and more than doubling over three years, powered by steady earnings growth. See our latest analysis for Hubbell. At around $456 per share, Hubbell’s recent 7 day share price return of just over 6% builds on a strong multi year total shareholder return. This suggests investors are steadily pricing in its consistent earnings execution rather than a one off catalyst. If Hubbell’s...

Earlier in December 2025, Apollo Global Management signaled a risk-off posture by hoarding cash, cutting exposure to CLOs and AI-related loans, and warning about systemic vulnerabilities in private credit and offshore insurance structures. This shift highlights how a large alternative asset manager can both reposition its own balance sheet and publicly flag potential fault lines in insurance-linked and tech-oriented credit markets. We’ll now examine how Apollo’s decision to prioritize...

Wondering if Sandisk is still worth buying after its massive run, or if the smart move now is to wait for a better entry point? Let us unpack whether the current price still stacks up to the company’s fundamentals. The stock has surged 20.9% over the last week, 10.2% over the past month, and an eye catching 594.7% year to date, putting it firmly on many investors’ watchlists and significantly changing how the market is pricing its future. Recent headlines have focused on Sandisk’s...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

As the U.S. stock market continues to reach new heights with the S&P 500 hitting an all-time high, investors are keenly observing opportunities that might be trading below their estimated value. In such a vibrant market environment, identifying undervalued stocks requires careful analysis of fundamentals and market positioning, making it essential to consider companies like Atour Lifestyle Holdings that may offer potential value at current prices.

As the U.S. stock market continues its upward trajectory, with major indices like the S&P 500 hitting all-time highs, investors are increasingly looking for opportunities in high-growth companies that insiders are eager to own. In this environment, companies with substantial insider ownership can be particularly attractive, as they often signal confidence in the company's future prospects and alignment of interests between management and shareholders.

As the U.S. stock market continues to reach new heights with the S&P 500 setting an all-time high, investors are keenly observing emerging opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, may still hold potential for those looking beyond established giants. Despite their vintage name, these stocks can offer surprising value and financial strength in today's dynamic market landscape.

As the U.S. stock market continues to climb, with the S&P 500 reaching new all-time highs and major indices showing consistent gains, investors are keenly observing opportunities in lesser-known sectors. In such a dynamic environment, identifying stocks with strong fundamentals and growth potential can be particularly rewarding for those looking to explore undiscovered gems in the market.

As the U.S. stock market continues its upward trajectory, with the S&P 500 hitting new all-time highs and major indices advancing, investors are keenly observing opportunities for stable returns amidst this bullish environment. In such a climate, dividend stocks can offer a reliable income stream and potential for capital appreciation, making them an attractive consideration for those looking to balance growth with income in their portfolios.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Key Insights American Resources' estimated fair value is US$4.44 based on 2 Stage Free Cash Flow to Equity American...

We'd be surprised if Ambarella, Inc. ( NASDAQ:AMBA ) shareholders haven't noticed that the Chief Financial Officer...

As the U.S. stock market reaches new heights with the S&P 500 closing at a record high, small-cap stocks are gaining attention amidst a robust economic backdrop marked by stronger-than-expected GDP growth. In this thriving environment, identifying small-cap companies with potential insider action can offer intriguing opportunities for investors looking to diversify their portfolios.